Catheter-based clot-dissolving drug for intermediate-high risk pulmonary embolism
Part of Blood & lymphatic, Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a blood clot in the main or large branches of the lung artery within the last 14 days.
- Your pulmonary embolism is considered intermediate-high risk, meaning your heart is strained (seen on an imaging test) and a blood test shows elevated heart stress markers.
- You do not have any condition that makes clot-dissolving medication unsafe, such as recent stroke, major bleeding, severe high blood pressure, or recent surgery.
- You are not pregnant, breastfeeding, or allergic to the study drugs.
- You do not have a serious active cancer or other major health issues listed in the exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
This study compares two ways to treat a large blood clot in the lungs that is causing life-threatening symptoms. One method uses a device to remove the clot, the other uses medicine to dissolve it.
This trial tests a new system to remove blood clots from the lungs in people with acute pulmonary embolism (a sudden blockage in a lung artery). It may help those who are stable enough for a catheter-based procedure but still have significant strain on the heart.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
This trial tests a new device (the Akura Thrombectomy System) that removes blood clots from the lungs in people with a sudden, severe pulmonary embolism. It aims to see if the device is safe and effective at improving blood flow and heart function.
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
Hear when a new Pulmonary Embolism Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.